Dollars and dilemmas: lenacapavir’s pricing, patents, and the path to affordability
Crossref DOI link: https://doi.org/10.1186/s12939-025-02610-3
Published Online: 2025-10-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Adepoju, Victor Abiola
Abdulrahim, Abdulrakib
Text and Data Mining valid from 2025-10-14
Version of Record valid from 2025-10-14
Article History
Received: 22 June 2025
Accepted: 12 August 2025
First Online: 14 October 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.